Surgical Science Sweden Stock Buy Hold or Sell Recommendation

SUSRF Stock  USD 12.75  0.00  0.00%   
Assuming the 90 days horizon and your below-average risk tolerance, our recommendation regarding Surgical Science Sweden is 'Strong Sell'. Macroaxis provides Surgical Science buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding SUSRF positions.
  
Check out Surgical Science Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
Note, we conduct extensive research on individual companies such as Surgical and provide practical buy, sell, or hold advice based on investors' constraints. Surgical Science Sweden. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Execute Surgical Science Buy or Sell Advice

The Surgical recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Surgical Science Sweden. Macroaxis does not own or have any residual interests in Surgical Science Sweden or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Surgical Science's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Surgical ScienceBuy Surgical Science
Strong Sell

Market Performance

WeakDetails

Volatility

Not too volatileDetails

Hype Condition

StaleDetails

Current Valuation

OvervaluedDetails

Odds Of Distress

LowDetails

Economic Sensitivity

Moves indifferently to market movesDetails

Analyst Consensus

Not AvailableDetails

Reporting Quality (M-Score)

InapplicableDetails
For the selected time horizon Surgical Science Sweden has a Mean Deviation of 0.5052, Standard Deviation of 1.85 and Variance of 3.43
Our advice tool can cross-verify current analyst consensus on Surgical Science and to analyze the firm potential to grow in the current economic cycle. To make sure Surgical Science Sweden is not overpriced, please validate all Surgical Science fundamentals, including its net income, as well as the relationship between the earnings per share and z score . Given that Surgical Science Sweden has a shares owned by institutions of 52.03 %, we advise you to double-check Surgical Science Sweden market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your current risk tolerance and investing horizon.

Surgical Science Trading Alerts and Improvement Suggestions

About 33.0% of the company outstanding shares are owned by corporate insiders

Surgical Science Returns Distribution Density

The distribution of Surgical Science's historical returns is an attempt to chart the uncertainty of Surgical Science's future price movements. The chart of the probability distribution of Surgical Science daily returns describes the distribution of returns around its average expected value. We use Surgical Science Sweden price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Surgical Science returns is essential to provide solid investment advice for Surgical Science.
Mean Return
0.04
Value At Risk
0.00
Potential Upside
0.00
Standard Deviation
1.85
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Surgical Science historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Surgical Science Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Surgical Science or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Surgical Science's price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Surgical pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over Dow Jones
0.05
β
Beta against Dow Jones-0.13
σ
Overall volatility
1.88
Ir
Information ratio -0.05

Surgical Science Volatility Alert

Surgical Science Sweden exhibits very low volatility with skewness of -0.25 and kurtosis of 20.25. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Surgical Science's pink sheet risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Surgical Science's pink sheet price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.

Surgical Science Fundamentals Vs Peers

Comparing Surgical Science's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Surgical Science's direct or indirect competition across all of the common fundamentals between Surgical Science and the related equities. This way, we can detect undervalued stocks with similar characteristics as Surgical Science or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of Surgical Science's fundamental indicators could also be used in its relative valuation, which is a method of valuing Surgical Science by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Surgical Science to competition
FundamentalsSurgical SciencePeer Average
Return On Equity0.0357-0.31
Return On Asset0.0212-0.14
Profit Margin0.18 %(1.27) %
Current Valuation743.09 M16.62 B
Shares Outstanding50.8 M571.82 M
Shares Owned By Insiders32.75 %10.09 %
Shares Owned By Institutions52.03 %39.21 %
Price To Earning73.41 X28.72 X
Price To Book2.26 X9.51 X
Price To Sales15.43 X11.42 X
Revenue366.78 M9.43 B
Gross Profit265.94 M27.38 B
EBITDA122.27 M3.9 B
Net Income86.25 M570.98 M
Total Debt29.42 M5.32 B
Debt To Equity0 %48.70 %
Current Ratio2.66 X2.16 X
Cash Flow From Operations39.08 M971.22 M
Earnings Per Share0.28 X3.12 X
Number Of Employees23318.84 K
Beta0.94-0.15
Market Capitalization833.72 M19.03 B
Total Asset3.98 B29.47 B
Z Score16.88.72
Net Asset3.98 B

Surgical Science Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Surgical . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Surgical Science Buy or Sell Advice

When is the right time to buy or sell Surgical Science Sweden? Buying financial instruments such as Surgical Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Surgical Science in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Tech Growth Thematic Idea Now

Tech Growth
Tech Growth Theme
Instruments that are typically traded at high earnings multiples compared to their competitors and other sectors and have been known to drive market cycles frequently. The Tech Growth theme has 66 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Tech Growth Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Surgical Pink Sheet

Surgical Science financial ratios help investors to determine whether Surgical Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Surgical with respect to the benefits of owning Surgical Science security.